Cookies on this website

We use cookies to ensure that we give you the best experience on our website. If you click 'Accept all cookies' we'll assume that you are happy to receive all cookies and you won't see this message again. If you click 'Reject all non-essential cookies' only necessary cookies providing core functionality such as security, network management, and accessibility will be enabled. Click 'Find out more' for information on how to change your cookie settings.

Pattern Recognition Receptor Polymorphisms as Predictors of Oxaliplatin Benefit in Colorectal Cancer.

Journal article

Gray V. et al, (2019), J Natl Cancer Inst, 111, 828 - 836

Association analyses identify 31 new risk loci for colorectal cancer susceptibility.

Journal article

Law PJ. et al, (2019), Nat Commun, 10

Duration of Adjuvant Chemotherapy for Stage III Colon Cancer.

Journal article

Grothey A. et al, (2018), N Engl J Med, 378, 1177 - 1188

Prognostic markers for colorectal cancer: estimating ploidy and stroma.

Journal article

Danielsen HE. et al, (2018), Ann Oncol, 29, 616 - 623

Pro-inflammatory fatty acid profile and colorectal cancer risk: A Mendelian randomisation analysis.

Journal article

May-Wilson S. et al, (2017), Eur J Cancer, 84, 228 - 238

Mendelian randomisation implicates hyperlipidaemia as a risk factor for colorectal cancer.

Journal article

Rodriguez-Broadbent H. et al, (2017), Int J Cancer, 140, 2701 - 2708

Is sidedness prognostically important across all stages of colorectal cancer?

Journal article

Kerr DJ. et al, (2016), Lancet Oncol, 17, 1480 - 1482

Mendelian randomisation analysis strongly implicates adiposity with risk of developing colorectal cancer.

Journal article

Jarvis D. et al, (2016), Br J Cancer, 115, 266 - 272

Load More